June 9, 2022
C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation: C-path announced it has been awarded a grant from the Frederick Gardner Cottrell Foundation, a non-profit organization established by Research Corporation Technologies, Inc. (RCT) that provides financial support for scientific research and educational programs, to create the C-Path Translational Therapeutics Accelerator (TRxA).
